Harnessing topological machine learning in Raman spectroscopy: Perspectives for Alzheimer's disease detection via cerebrospinal fluid analysis

被引:0
|
作者
Conti, Francesco [1 ,2 ]
Banchelli, Martina [3 ]
Bessi, Valentina [4 ]
Cecchi, Cristina [5 ]
Chiti, Fabrizio [5 ]
Colantonio, Sara [1 ]
D'Andrea, Cristiano [3 ]
de Angelis, Marella [3 ]
Moroni, Davide [1 ]
Nacmias, Benedetta [4 ,6 ]
Pascali, Maria Antonietta [1 ]
Sorbi, Sandro [4 ,6 ]
Matteini, Paolo [3 ]
机构
[1] Italian Natl Res Council, Inst Informat Sci & Technol A Faedo, Via G Moruzzi 1, I-56124 Pisa, PI, Italy
[2] Univ Pisa, Dept Math, Largo B Pontecorvo 5, I-56126 Pisa, Italy
[3] CNR, Inst Appl Phys N Carrara, Via Madonna Piano 10, I-50019 Sesto Fiorentino, FI, Italy
[4] Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth, Viale Pieraccini 6, I-50139 Florence, FI, Italy
[5] Univ Florence, Dept Expt & Clin Biomed Sci, Viale Morgagni 50, I-50134 Florence, FI, Italy
[6] IRCCS Fdn Don Carlo Gnocchi, Via Scandicci 269, I-50143 Florence, FI, Italy
关键词
Raman spectroscopy; Cerebrospinal fluid; Alzheimer's disease; Persistent homology; Topological data analysis; Topological machine learning; DIAGNOSIS;
D O I
10.1016/j.jfranklin.2024.107249
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
The cerebrospinal fluid of 21 subjects who received a clinical diagnosis of Alzheimer's disease (AD) as well as of 22 pathological controls has been collected and analysed by Raman spectroscopy (RS). We investigated whether the Raman spectra could be used to distinguish AD from controls, after a preprocessing procedure. We applied machine learning to a set of topological descriptors extracted from the spectra, achieving a high classification accuracy of 86%. Our experimentation indicates that RS and topological analysis may be a reliable and effective combination to confirm or disprove a clinical diagnosis of Alzheimer's disease. The following steps will aim at leveraging the intrinsic interpretability of the topological data analysis to characterize the AD subtypes, e.g. by identifying the bands of the Raman spectrum relevant for AD detection, possibly increasing and/or confirming the knowledge about the precise molecular events and biological pathways behind the Alzheimer's disease.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] ADVANCED PERSPECTIVES FOR THE DIAGNOSIS OF PARKINSON'S AND ALZHEIMER'S DISEASE THROUGH MACHINE LEARNING TECHNIQUES
    Malvaso, A.
    Panarese, S.
    Catalano, M.
    Migliore, M.
    Caligiore, D.
    PARKINSONISM & RELATED DISORDERS, 2024, 122
  • [42] Detection of Aβ40 in cerebrospinal fluid and plasma of Alzheimer’s disease patients using photoelectrochemical biosensors
    Li, Liting
    Wei, Na
    Guo, Yiwei
    Zhu, Xingyu
    Wang, Lin
    Zhu, Yanzhao
    Fang, Ke
    Ma, Shenhui
    Zhang, Yingying
    Zhang, Yan
    Zhou, Xiaofei
    Zhao, Gang
    Bu, Yuyu
    Zhou, Linfu
    Microchimica Acta, 2025, 192 (01)
  • [43] Immunocytochemical detection of anti-hippocampal antibodies in Alzheimer's disease and normal cerebrospinal fluid
    Loeffler, DA
    Juneau, PL
    Nguyen, HU
    Najman, D
    Pomara, N
    LeWitt, PA
    NEUROCHEMICAL RESEARCH, 1997, 22 (02) : 209 - 214
  • [44] Proteomic Analysis of Alzheimer's Disease Cerebrospinal Fluid from Neuropathologically Diagnosed Subjects
    Maarouf, Chera L.
    Andacht, Tracy M.
    Kokjohn, Tyler A.
    Castano, Eduardo M.
    Sue, Lucia I.
    Beach, Thomas G.
    Roher, Alex E.
    CURRENT ALZHEIMER RESEARCH, 2009, 6 (04) : 399 - 406
  • [45] Magnetic Resonance Imaging Improves Cerebrospinal Fluid Biomarkers in the Early Detection of Alzheimer's Disease
    Brys, Miroslaw
    Glodzik, Lidia
    Mosconi, Lisa
    Switalski, Remigiusz
    De Santi, Susan
    Pirraglia, Elizabeth
    Rich, Kenneth
    Kim, Byeong C.
    Mehta, Pankaj
    Zinkowski, Ray
    Pratico, Domenico
    Wallin, Anders
    Zetterberg, Henrik
    Tsui, Wai H.
    Rusinek, Henry
    Blennow, Kaj
    de Leon, Mony J.
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 16 (02) : 351 - 362
  • [46] Immunocytochemical Detection of Anti-Hippocampal Antibodies in Alzheimer's Disease and Normal Cerebrospinal Fluid
    David A. Loeffler
    Paul L. Juneau
    Hanh-Uyen Nguyen
    Dina Najman
    Nunzio Pomara
    Peter A. LeWitt
    Neurochemical Research, 1997, 22 : 209 - 214
  • [47] Towards development of a novel screening method for identifying Alzheimer's disease risk: Raman spectroscopy of blood serum and machine learning
    Ralbovsky, Nicole M.
    Fitzgerald, Greg S.
    McNay, Ewan C.
    Lednev, Igor K.
    SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2021, 254
  • [48] Cerebrospinal fluid orexin in Alzheimer's disease: a systematic review and meta-analysis
    Treu, Spencer P.
    Plante, David T.
    SLEEP MEDICINE, 2021, 85 : 230 - 238
  • [49] Measurement of fluorescent probes concentration ratio in the cerebrospinal fluid for early detection of Alzheimer's disease
    Harbater, Osnat
    Gannot, Israel
    OPTICAL BIOPSY XII, 2014, 8940
  • [50] Quantitative Mass Spectrometry Analysis of Cerebrospinal Fluid Protein Biomarkers in Alzheimer’s Disease
    Caroline M. Watson
    Eric B. Dammer
    Lingyan Ping
    Duc M. Duong
    Erica Modeste
    E. Kathleen Carter
    Erik C. B. Johnson
    Allan I. Levey
    James J. Lah
    Blaine R. Roberts
    Nicholas T. Seyfried
    Scientific Data, 10